Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells

Area of Science:

• Rheumatology
• Stem Cell Biology
• Cellular Biology

Background:

• Mesenchymal progenitor/stem cells (MPCs) are of increasing interest in rheumatology.
• The in vivo phenotype of MPCs in rheumatic diseases remains largely unknown.
• Understanding MPC characteristics is vital for potential therapeutic applications.

Purpose of the Study:

• To isolate and characterize human bone marrow (BM) MPCs.
• To define the distinct phenotype and morphology of BM MPCs.
• To establish a reliable method for MPC isolation.

Main Methods:

• Utilized fluorescence microscopy to identify putative MPCs.
• Employed positive selection with antifibroblast microbeads and fluorescence-activated cell sorting (FACS) for purification.
• Conducted 4-color flow cytometry for detailed phenotyping and standard differentiation assays (chondrogenic, osteogenic, adipogenic).

Main Results:

• Successfully isolated MPCs, identified as D7-FIB+ fibroblast-like cells, representing 0.01% of mononuclear BM cells.
• Characterized MPCs as uniformly positive for CD105, LNGFR, HLA-DR, CD10, CD13, CD90, STRO-1, and BMPRIA, and negative for CD14, CD34, CD117, and CD133.
• Demonstrated that only cells with this specific phenotype exhibited proliferative capacity and multipotent differentiation potential.

Conclusions:

• This study successfully defined the distinct phenotype, morphology, and isolation method for human bone marrow MPCs.
• The findings provide a foundation for understanding the physiological roles of MPCs in arthritis, bone diseases, and joint regeneration.
• The characterized BM MPCs hold potential for future therapeutic strategies in regenerative medicine.